Basilea Pharmaceutica AG
Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles

Abstract:

Use of glu-tubulin as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject to said compound, wherein the compound is a furazanobenzimidazole compound of general formula (I). ##STR00001##